CAS 2088410-46-0

GSK620

Description:

GSK620, identified by its CAS number 2088410-46-0, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure includes functional groups that facilitate its interaction with biological targets, making it a subject of interest in drug discovery. GSK620 has been studied for its role in modulating immune responses and may have implications in the treatment of autoimmune disorders or other conditions where immune regulation is crucial. As with many investigational compounds, its safety, efficacy, and pharmacokinetic properties are evaluated through preclinical and clinical studies. However, detailed information regarding its specific characteristics, such as solubility, stability, and mechanism of action, would typically be found in specialized scientific literature or databases dedicated to chemical substances and pharmaceuticals.

Formula: C₁₈H₁₉N₃O₃

Synonyms:

• 1-benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide
• GSK620

GSK620

CAS: 2088410-46-0

GSK620

Purity: ≥98%

Molecular weight: 325.36g/mol

Ref: 54-BUP08263

GSK620

CAS: 2088410-46-0

GSK620, a selective pan-BD2 inhibitor, has anti-inflammatory properties and favorable oral pharmacokinetics.

Formula: C₁₈H₁₉N₃O₃

Purity: 99.42% - 99.88%

Color and Shape: Solid

Molecular weight: 325.36

Ref: TM-T9020

1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide

CAS: 2088410-46-0

1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide is a potent and selective inhibitor of the ion channel TRPV4. It binds to the receptor with an IC50 of 0.2 μM. This compound has been shown to inhibit TRPV4 in human embryonic kidney cells (HEK293) and HEK293 cells stably expressing TRPV4. The inhibition of TRPV4 by 1BPNDC has been shown to be concentration dependent. This compound is suitable for research purposes such as pharmacology, protein interactions, receptor binding, peptides activation, ion channels ligand, cell biology and antibody production.

Formula: C₁₈H₁₉N₃O₃

Purity: Min. 95%

Molecular weight: 325.4 g/mol

Ref: 3D-NID41046